IGF1 and neoplasm: There are also indirect antiproliferative effects; through the inhibition of circulating growth factors (e.g. insulin-like growth factor 1 and vascular endothelial growth factor) and through the inhibition of tumour angiogenesis by altering the release of nitric oxide (Gomes-Porras et al. 2020).